Yu et al. (Yu et al., 2021) observed elevated mRNA levels of CD160 in diffuse large B cell lymphoma, especially in subtype I, which displayed poorer overall survival time and progression-free survival time than those in subtype II. The gene discussed is CD160; the disease is diffuse large B-cell lymphoma.